SG Americas Securities LLC Increases Holdings in Chemed Co. (NYSE:CHE)

SG Americas Securities LLC grew its holdings in Chemed Co. (NYSE:CHE) by 422.9% in the 2nd quarter, according to the company in its most recent filing with the SEC. The firm owned 7,551 shares of the company’s stock after buying an additional 6,107 shares during the quarter. SG Americas Securities LLC’s holdings in Chemed were worth $4,097,000 at the end of the most recent quarter.

A number of other large investors have also recently made changes to their positions in the business. OLD National Bancorp IN purchased a new stake in shares of Chemed in the 2nd quarter worth about $313,000. Linden Thomas Advisory Services LLC lifted its holdings in Chemed by 8.4% in the second quarter. Linden Thomas Advisory Services LLC now owns 7,596 shares of the company’s stock worth $4,121,000 after buying an additional 589 shares during the period. CWM LLC boosted its position in Chemed by 18.5% during the 2nd quarter. CWM LLC now owns 397 shares of the company’s stock valued at $215,000 after acquiring an additional 62 shares in the last quarter. Harbor Capital Advisors Inc. grew its holdings in shares of Chemed by 292.7% during the 2nd quarter. Harbor Capital Advisors Inc. now owns 1,241 shares of the company’s stock worth $673,000 after acquiring an additional 925 shares during the period. Finally, Mather Group LLC. raised its position in shares of Chemed by 60.5% in the 2nd quarter. Mather Group LLC. now owns 183 shares of the company’s stock worth $99,000 after acquiring an additional 69 shares in the last quarter. 95.85% of the stock is currently owned by institutional investors.

Insider Transactions at Chemed

In related news, Director Patrick P. Grace sold 284 shares of the firm’s stock in a transaction that occurred on Wednesday, June 12th. The shares were sold at an average price of $540.98, for a total transaction of $153,638.32. Following the completion of the sale, the director now owns 3,270 shares of the company’s stock, valued at $1,769,004.60. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. In related news, Director Patrick P. Grace sold 284 shares of the stock in a transaction on Wednesday, June 12th. The stock was sold at an average price of $540.98, for a total transaction of $153,638.32. Following the sale, the director now directly owns 3,270 shares of the company’s stock, valued at $1,769,004.60. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Also, CEO Kevin J. Mcnamara sold 1,500 shares of Chemed stock in a transaction dated Thursday, June 6th. The stock was sold at an average price of $544.17, for a total value of $816,255.00. Following the completion of the sale, the chief executive officer now owns 107,049 shares of the company’s stock, valued at $58,252,854.33. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 9,784 shares of company stock worth $5,502,473. Corporate insiders own 3.32% of the company’s stock.

Chemed Stock Down 1.0 %

Shares of CHE opened at $573.71 on Tuesday. The stock has a market cap of $8.69 billion, a P/E ratio of 30.88, a P/E/G ratio of 2.40 and a beta of 0.43. The business’s 50 day moving average price is $547.94 and its 200-day moving average price is $581.90. Chemed Co. has a 52 week low of $492.84 and a 52 week high of $654.62.

Chemed (NYSE:CHE) last released its earnings results on Wednesday, July 24th. The company reported $5.47 EPS for the quarter, missing the consensus estimate of $5.59 by ($0.12). Chemed had a return on equity of 29.21% and a net margin of 12.88%. The company had revenue of $595.88 million during the quarter, compared to the consensus estimate of $599.20 million. During the same period last year, the firm posted $4.71 earnings per share. The company’s revenue was up 7.6% compared to the same quarter last year. On average, equities analysts anticipate that Chemed Co. will post 21.77 EPS for the current year.

Chemed Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, August 30th. Shareholders of record on Monday, August 12th will be issued a $0.50 dividend. The ex-dividend date is Monday, August 12th. This is a boost from Chemed’s previous quarterly dividend of $0.40. This represents a $2.00 annualized dividend and a yield of 0.35%. Chemed’s payout ratio is 10.76%.

Wall Street Analysts Forecast Growth

Several research firms recently weighed in on CHE. Royal Bank of Canada dropped their price target on Chemed from $712.00 to $697.00 and set an “outperform” rating on the stock in a research report on Tuesday, May 21st. StockNews.com raised shares of Chemed from a “hold” rating to a “buy” rating in a research report on Saturday, May 4th.

About Chemed

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.